Evidence map›Paper›PMID 15914818›Full record

ArticleAmerican journal of public health2005

Free nicotine replacement therapy programs vs implementing smoke-free workplaces: a cost-effectiveness comparison.

Michael K Ong, Stanton A Glantz

Open access · greenAbstract readComparative StudyEvaluation Study
In one paragraph

Article in American journal of public health, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 4 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 4 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Workplace interventions for smoking cessation.The Cochrane database of systematic reviews · 2014
    Pooled it
  5. Review
  6. Article
  7. Influence of Disclosed and Undisclosed Funding Sources in Tobacco Harm Reduction Discourse: A Social Network Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. A review of economic evaluations of tobacco control programs.International journal of environmental research and public health · 2009
    Review
  16. Article
  17. Cost-effectiveness of smoking cessation to prevent age-related macular degeneration.Cost effectiveness and resource allocation : C/E · 2008
    Article
  18. Article
  19. Article
  20. Smokefree environments in Latin America: on the road to real change?Prevention and control : the official journal of the World Heart Federation · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael K OngVA Palo Alto Health Care System, CA, USA.
Stanton A Glantz
VA Palo Alto Health Care System · US

Funding

TOBACCO ADVOCACY AT THE STATE LEVELR01CA061021 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLANTZ, STANTON ARNOLD · 1994 to 2015
$7.4M
NCI NIH HHS CA-61021NCI NIH HHS R01 CA061021PHS HHS 1D22HPO00349
6 · The paper itself

Abstract

We compared the cost-effectiveness of a free nicotine replacement therapy (NRT) program with a statewide smoke-free workplace policy in Minnesota. We conducted 1-year simulations of costs and benefits. The number of individuals who quit smoking and the quality-adjusted life years (QALYs) were the measures of benefits. After 1 year, a NRT program generated 18,500 quitters at a cost of 7020 dollars per quitter (4440 dollars per QALY), and a smoke-free workplace policy generated 10,400 quitters at a cost of 799 dollars per quitter (506 dollars per QALY). Smoke-free work-place policies are about 9 times more cost-effective per new nonsmoker than free NRT programs are. Smoke-free workplace policies should be a public health funding priority, even when the primary goal is to promote individual smoking cessation.

Indexed as

Quality-Adjusted Life YearsSmoking PreventionAdolescentAdultCost-Benefit AnalysisFinancing, GovernmentHealth PromotionHumansMiddle AgedMinnesotaNicotineSmokingSmoking CessationState GovernmentTobacco Smoke PollutionWorkplaceNicotineTobacco Smoke Pollution

Identifiers

PMID15914818
PMCPMC1449293
OpenAlexW1983858123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.